Bryan Cave is advising Zevra, and Pillsbury is advising Acer Therapeutics. Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) and Acer Therapeutics Inc. (Nasdaq: ACER) announced the companies have entered into...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here